Innoviva, Inc. 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-11 5:27 pm Sale | 2022-07-07 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 100 100.000% | -57,345,694 (-100.00%) | Filing |
| 2022-05-23 8:55 pm Unchanged | 2022-05-23 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing |
| 2022-03-15 09:00 am Unchanged | 2022-03-15 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing |
| 2022-02-18 8:47 pm Unchanged | 2022-02-17 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 57,345,794 75.150% | 0 (Unchanged) | Filing |
| 2022-02-01 6:34 pm Unchanged | 2022-02-01 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 57,345,794 75.150% | 0 (Unchanged) | Filing |
| 2021-06-11 5:37 pm Purchase | 2021-06-11 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 57,345,794 75.500% | 12,537,950 (+27.98%) | Filing |
| 2021-05-03 5:19 pm Purchase | 2021-05-03 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 44,807,844 70.600% | 7,462,050 (+19.98%) | Filing |
| 2020-09-01 5:28 pm Purchase | 2020-09-01 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 37,345,794 69.000% | 9,345,794 (+33.38%) | Filing |
| 2020-08-31 3:10 pm Unchanged | 2020-08-27 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 28,000,000 67.800% | 0 (Unchanged) | Filing |
| 2020-06-12 5:30 pm Purchase | 2020-06-11 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 28,000,000 67.800% | 25,354,980 (+958.59%) | Filing |
| 2020-04-23 5:00 pm Purchase | 2020-04-22 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 2,645,020 19.996% | 2,645,020 (New Position) | Filing |